ApprovalTrail

Approval · Notice of Compliance 7823 · 2006

VOLUVEN: Notice of Compliance 7823

Issued March 10, 2006

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
7823
Date
March 10, 2006
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Other
Therapeutic class
Plasma volume expander

Products in this notice

BrandDINStatus today
VOLUVEN02278057Marketed

Medicinal ingredients